Korean Pharma Highlights R&D Progress, 2020 Strategy At JPM
Obesity Emerges As Key Theme
Among the Korean firms presenting at J.P. Morgan, Hanmi laid out its strategy for obesity and other core pipeline assets, Celltrion focused on its expanding biosimilar pipeline and China plans and LG Chem unveiled new R&D progress.
